• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY ULTRAFLEX¿ ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY ULTRAFLEX¿ ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513750
Device Problems Device Markings/Labelling Problem (2911); Positioning Problem (3009)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/22/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device has not been received for analysis; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2018 that an ultraflex esophageal ng distal release covered stent was to be used treat a 10-cm malignant stricture in the esophagus during a stenting procedure performed on (b)(6) 2018.Reportedly, the patient's anatomy was tight and was not dilated prior to stent placement.According to the complainant, during fluoroscopic stent deployment, the stent began to release from the proximal end of the delivery catheter, and then the stent was deployed in an incorrect location.Reportedly, the complainant confirmed that the device packaging label indicates a distal release stent (and not a proximal release stent).The stent was removed with forceps and the procedure was completed with another ultraflex esophageal stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
A deployed ultraflex esophageal covered stent was received for analysis; the box and the delivery system were not returned.The stent was received expanded.Visual examination identified no damage or issue with the stent.The green retention suture was inspected and no anomalies were noted in both ends.The investigation concluded that the reported event was likely due to anatomical or procedural factors encountered during the procedure which limited the performance of the device.Therefore, the most probably root cause is operational context.A labeling review was performed, and from the information available this device was used per the directions for use (dfu)/product label.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly and performance specifications at the time of release for distribution.A search of the complaint database confirmed that no other similar complaints exist for the specified lot.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2018 that an ultraflex esophageal ng distal release covered stent was to be used treat a 10-cm malignant stricture in the esophagus during a stenting procedure performed on (b)(6) 2018.Reportedly, the patient's anatomy was tight and was not dilated prior to stent placement.According to the complainant, during fluoroscopic stent deployment, the stent began to release from the proximal end of the delivery catheter, and then the stent was deployed in an incorrect location.Reportedly, the complainant confirmed that the device packaging label indicates a distal release stent (and not a proximal release stent).The stent was removed with forceps and the procedure was completed with another ultraflex esophageal stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX¿ ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
nancy cutino
100 boston scientific way
marlborough, MA 01752
5086834000
MDR Report Key7603466
MDR Text Key111136845
Report Number3005099803-2018-01934
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729649113
UDI-Public08714729649113
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/21/2019
Device Model NumberM00513750
Device Catalogue Number1375
Device Lot Number21285057
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/06/2018
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/22/2018
Initial Date FDA Received06/14/2018
Supplement Dates Manufacturer Received08/30/2018
Supplement Dates FDA Received09/21/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age47 YR
-
-